Cardiovascular system | |||||
---|---|---|---|---|---|
Cardiovascular system / Patent ductus arteriosus | |||||
alprostadil | |||||
Powder and solvent for solution for injection | |||||
Caverject (Pfizer Ltd) | |||||
Viridal (Advanz Pharma) | |||||
Stick | |||||
Muse (Viatris UK Healthcare Ltd) | |||||
Cutaneous cream | |||||
Vitaros (The Simple Pharma Company UK Ltd) | |||||
dinoprostone | Hospital only | ||||
Pessary | |||||
Prostin E2 (Pfizer Ltd) | |||||
Vaginal device | |||||
Propess (Ferring Pharmaceuticals Ltd) | Hospital only | ||||
Vaginal gel | |||||
Prostin E2 (Pfizer Ltd) | Hospital only | ||||
ibuprofen | |||||
Orodispersible tablet | |||||
Nurofen Meltlets (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
Modified-release tablet | |||||
Brufen Retard (Viatris UK Healthcare Ltd) | |||||
Chewable capsule | |||||
Nurofen (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
Modified-release capsule | |||||
Ibuprofen (Non-proprietary) | |||||
Galprofen Long Lasting (Galpharm International Ltd) | |||||
Nurofen Long Lasting (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
Effervescent granules | |||||
Brufen (Viatris UK Healthcare Ltd) | |||||
Oral suspension | |||||
Ibuprofen (Non-proprietary) | |||||
Brufen (Viatris UK Healthcare Ltd) | |||||
Nurofen (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
Solution for infusion | |||||
Ibuprofen (Non-proprietary) | |||||
Pedea (Recordati Rare Diseases UK Ltd) | |||||
Oral tablet | |||||
Ibuprofen (Non-proprietary) | |||||
Brufen (Viatris UK Healthcare Ltd) | |||||
Feminax Express (Bayer Plc) | |||||
Nurofen (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
Nurofen Express (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
Nurofen Joint & Back Pain Relief (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
Nurofen Migraine Pain (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
Oral capsule | |||||
Ibuprofen (Non-proprietary) | |||||
Flarin (infirst Ltd) | |||||
Nurofen Express (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
Cutaneous gel | |||||
Ibuprofen (Non-proprietary) | |||||
Ibugel (Dermal Laboratories Ltd) | |||||
Ibuleve (Diomed Developments Ltd) | |||||
Phorpain (Advanz Pharma) | |||||
Cardiovascular system / Arrhythmias | |||||
acebutolol | Not approved for prescribing | ||||
Oral tablet | |||||
Acebutolol (Non-proprietary) | |||||
adenosine | Hospital only | ||||
Solution for injection | |||||
Adenosine (Non-proprietary) | Hospital only | ||||
Adenocor (Sanofi) | Hospital only | ||||
Solution for infusion | |||||
Adenosine (Non-proprietary) | Hospital only | ||||
Adenoscan (Sanofi) | Hospital only | ||||
amiodarone hydrochloride | Specialist knowledge/initiation | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Solution for injection | |||||
Amiodarone hydrochloride (Non-proprietary) | Hospital only | ||||
Cordarone X (Sanofi) | Hospital only | ||||
Oral tablet | |||||
Amiodarone hydrochloride (Non-proprietary) | |||||
Cordarone X (Zentiva Pharma UK Ltd) | |||||
atenolol | Joint formulary choice | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Oral solution | |||||
Atenolol (Non-proprietary) | Joint formulary choice | ||||
Solution for injection | |||||
Tenormin (Atnahs Pharma UK Ltd) | Hospital only | ||||
Oral tablet | |||||
Atenolol (Non-proprietary) | |||||
Tenormin (Atnahs Pharma UK Ltd) | |||||
atropine sulfate | Hospital only | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Solution for injection | |||||
Atropine sulfate (Non-proprietary) | Hospital only | ||||
Eye drops | |||||
Atropine sulfate (Non-proprietary) | |||||
digoxin | Specialist knowledge/initiation | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Oral solution | |||||
Digoxin (Non-proprietary) | |||||
Solution for injection | |||||
Digoxin (Non-proprietary) | Hospital only | ||||
Solution for infusion | |||||
Digoxin (Non-proprietary) | |||||
Oral tablet | |||||
Digoxin (Non-proprietary) | |||||
disopyramide | Hospital only | ||||
Modified-release tablet | |||||
Rythmodan Retard (Neon Healthcare Ltd) | Hospital only | ||||
Oral capsule | |||||
Rythmodan (Neon Healthcare Ltd) | |||||
dronedarone | Hospital only |
NICE TA197 |
|||
Oral tablet | |||||
Dronedarone (Non-proprietary) | |||||
Multaq (Sanofi) | |||||
esmolol hydrochloride | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Solution for injection | |||||
Esmolol hydrochloride (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Brevibloc (Baxter Healthcare Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Solution for infusion | |||||
Esmolol hydrochloride (Non-proprietary) | |||||
Brevibloc (Baxter Healthcare Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
flecainide acetate | Specialist knowledge/initiation | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Oral tablet | |||||
Flecainide acetate (Non-proprietary) | |||||
landiolol hydrochloride | |||||
Powder for solution for infusion | |||||
Rapibloc (AOP Orphan Ltd) | |||||
lidocaine hydrochloride | Hospital only | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Solution for injection | |||||
Lidocaine hydrochloride (Non-proprietary) | Hospital only | ||||
Ointment | |||||
Lidocaine hydrochloride (Non-proprietary) | |||||
Spray | |||||
Stud 100 (Pound International Ltd) | |||||
Xylocaine (Aspen Pharma Trading Ltd) | |||||
Medicated plaster | |||||
Ralvo (Grunenthal Ltd) | |||||
Versatis (Grunenthal Ltd) | |||||
Cutaneous cream | |||||
LMX 4 (Ferndale Pharmaceuticals Ltd) | |||||
Vagisil medicated (Combe International Ltd) | |||||
metoprolol tartrate | Joint formulary choice | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Solution for injection | |||||
Betaloc (Recordati Pharmaceuticals Ltd) | Hospital only | ||||
Oral tablet | |||||
Metoprolol tartrate (Non-proprietary) | |||||
mexiletine | Not approved for prescribing |
NICE TA748 |
|||
Oral capsule | |||||
Mexiletine (Non-proprietary) | |||||
Namuscla (Lupin Healthcare (UK) Ltd) | |||||
nadolol | Not approved for prescribing | ||||
Oral tablet | |||||
Nadolol (Non-proprietary) | |||||
propafenone hydrochloride | Hospital only | ||||
Oral tablet | |||||
Propafenone hydrochloride (Non-proprietary) | |||||
Arythmol (Viatris UK Healthcare Ltd) | |||||
propranolol hydrochloride | Specialist knowledge/initiation | ||||
Modified-release capsule | |||||
Bedranol SR (Almus Pharmaceuticals Ltd, Sandoz Ltd) | Specialist knowledge/initiation | ||||
Beta-Prograne (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Half Beta-Prograne (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Oral solution | |||||
Propranolol hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Propranolol hydrochloride (Non-proprietary) | |||||
sotalol hydrochloride | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Sotalol hydrochloride (Non-proprietary) | |||||
verapamil hydrochloride | Specialist knowledge/initiation | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Verapamil for cluster headaches
Oral verapamil for cluster headaches should be prescribed under the explicit direction of a specialist only. |
|||||
Modified-release tablet | |||||
Half Securon (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
Verapamil for cluster headaches
Oral verapamil for cluster headaches should be prescribed under the explicit direction of a specialist only. |
|||||
Securon SR (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
Verapamil for cluster headaches
Oral verapamil for cluster headaches should be prescribed under the explicit direction of a specialist only. |
|||||
Vera-Til SR (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Verapamil for cluster headaches
Oral verapamil for cluster headaches should be prescribed under the explicit direction of a specialist only. |
|||||
Verapress MR (Dexcel-Pharma Ltd) | Specialist knowledge/initiation | ||||
Verapamil for cluster headaches
Oral verapamil for cluster headaches should be prescribed under the explicit direction of a specialist only. |
|||||
Oral solution | |||||
Verapamil hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
Verapamil for cluster headaches
Oral verapamil for cluster headaches should be prescribed under the explicit direction of a specialist only. |
|||||
Solution for injection | |||||
Securon (Viatris UK Healthcare Ltd) | Hospital only | ||||
Oral tablet | |||||
Verapamil hydrochloride (Non-proprietary) | |||||
vernakalant | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
Solution for infusion | |||||
Brinavess (Correvio UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Cardiovascular system / Hypertension | |||||
acebutolol | Not approved for prescribing | ||||
Oral tablet | |||||
Acebutolol (Non-proprietary) | |||||
aliskiren | Not approved for prescribing | ||||
Oral tablet | |||||
Rasilez (Noden Pharma DAC) | |||||
amiloride hydrochloride | Joint formulary choice | ||||
Oral solution | |||||
Amiloride hydrochloride (Non-proprietary) | Joint formulary choice | ||||
Oral tablet | |||||
Amiloride hydrochloride (Non-proprietary) | |||||
amlodipine | Joint formulary choice | ||||
Oral suspension | |||||
Amlodipine (Non-proprietary) | |||||
Oral solution | |||||
Amlodipine (Non-proprietary) | Not approved for prescribing | ||||
Oral tablet | |||||
Amlodipine (Non-proprietary) | |||||
Istin (Viatris UK Healthcare Ltd) | |||||
amlodipine with valsartan | Not approved for prescribing | ||||
Oral tablet | |||||
Amlodipine with valsartan (Non-proprietary) | |||||
Exforge (Novartis Pharmaceuticals UK Ltd) | |||||
atenolol | Joint formulary choice | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Oral solution | |||||
Atenolol (Non-proprietary) | Joint formulary choice | ||||
Solution for injection | |||||
Tenormin (Atnahs Pharma UK Ltd) | Hospital only | ||||
Oral tablet | |||||
Atenolol (Non-proprietary) | |||||
Tenormin (Atnahs Pharma UK Ltd) | |||||
azilsartan medoxomil | Not approved for prescribing | ||||
Oral tablet | |||||
Edarbi (Takeda UK Ltd) | |||||
bendroflumethiazide | Joint formulary choice | ||||
Oral tablet | |||||
Bendroflumethiazide (Non-proprietary) | |||||
bisoprolol fumarate | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Bisoprolol fumarate (Non-proprietary) | |||||
Cardicor (Merck Serono Ltd) | |||||
candesartan cilexetil | Joint formulary choice | ||||
Oral tablet | |||||
Candesartan cilexetil (Non-proprietary) | |||||
Amias (Neon Healthcare Ltd) | |||||
captopril | Not approved for prescribing | ||||
Oral solution | |||||
Captopril (Non-proprietary) | Not approved for prescribing | ||||
Oral tablet | |||||
Captopril (Non-proprietary) | |||||
carvedilol | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Carvedilol (Non-proprietary) | |||||
celiprolol hydrochloride | Not approved for prescribing | ||||
Oral tablet | |||||
Celiprolol hydrochloride (Non-proprietary) | |||||
Celectol (Neon Healthcare Ltd) | |||||
chlortalidone | Joint formulary choice | ||||
Oral tablet | |||||
Chlortalidone (Non-proprietary) | |||||
Hylaton (Morningside Healthcare Ltd) | |||||
clonidine hydrochloride | Specialist knowledge/initiation | ||||
Clonidine for the management of ADHD is hospital only
Clonidine for the management of ADHD should only be prescribed in secondary care. |
|||||
Oral solution | |||||
Clonidine hydrochloride (Non-proprietary) | |||||
Oral tablet | |||||
Clonidine hydrochloride (Non-proprietary) | |||||
Catapres (Glenwood GmbH) | |||||
co-amilozide | Not approved for prescribing | ||||
Oral tablet | |||||
Co-amilozide (Non-proprietary) | |||||
co-tenidone | Not approved for prescribing | ||||
Oral tablet | |||||
Co-tenidone (Non-proprietary) | |||||
Tenoret (Atnahs Pharma UK Ltd) | |||||
Tenoretic (Atnahs Pharma UK Ltd) | |||||
diltiazem hydrochloride | Joint formulary choice | ||||
Modified-release tablet | |||||
Diltiazem hydrochloride (Non-proprietary) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Retalzem (Kent Pharma (UK) Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Tildiem (Sanofi) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Tildiem Retard (Sanofi) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Zeyam (Ennogen Pharma Ltd) | |||||
Modified-release capsule | |||||
Adizem-SR (Napp Pharmaceuticals Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Adizem-XL (Napp Pharmaceuticals Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Angitil SR (Ethypharm UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Angitil XL (Ethypharm UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Slozem (Zentiva Pharma UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Tildiem LA (Sanofi) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Viazem XL (Thornton & Ross Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Zemtard XL (Galen Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
doxazosin | Joint formulary choice | ||||
Modified-release tablet | |||||
Cardura XL (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
Doxadura XL (Dexcel-Pharma Ltd) | Not approved for prescribing | ||||
Larbex XL (Teva UK Ltd) | Not approved for prescribing | ||||
Raporsin XL (Accord-UK Ltd) | Not approved for prescribing | ||||
Oral tablet | |||||
Doxazosin (Non-proprietary) | |||||
Cardura (Viatris UK Healthcare Ltd) | |||||
Doxadura (Dexcel-Pharma Ltd) | |||||
enalapril maleate | Joint formulary choice | ||||
Oral solution | |||||
Enalapril maleate (Non-proprietary) | |||||
Oral tablet | |||||
Enalapril maleate (Non-proprietary) | |||||
Innovace (Organon Pharma (UK) Ltd) | |||||
enalapril with hydrochlorothiazide | Not approved for prescribing | ||||
Oral tablet | |||||
Enalapril with hydrochlorothiazide (Non-proprietary) | |||||
Innozide (Organon Pharma (UK) Ltd) | |||||
eprosartan | Not approved for prescribing | ||||
Oral tablet | |||||
Eprosartan (Non-proprietary) | |||||
Teveten (Viatris UK Healthcare Ltd) | |||||
esmolol hydrochloride | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Solution for injection | |||||
Esmolol hydrochloride (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Brevibloc (Baxter Healthcare Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Solution for infusion | |||||
Esmolol hydrochloride (Non-proprietary) | |||||
Brevibloc (Baxter Healthcare Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
felodipine | Not approved for prescribing | ||||
Modified-release tablet | |||||
Cardioplen XL (Chiesi Ltd) | Not approved for prescribing | ||||
Delofine XL (Morningside Healthcare Ltd) | |||||
Felendil XL (Teva UK Ltd) | Not approved for prescribing | ||||
Felotens XL (Thornton & Ross Ltd) | |||||
Neofel XL (Kent Pharma (UK) Ltd) | |||||
Parmid XL (Sandoz Ltd) | Not approved for prescribing | ||||
Pinefeld XL (Tillomed Laboratories Ltd) | |||||
Vascalpha (Accord-UK Ltd) | Not approved for prescribing | ||||
fosinopril sodium | Not approved for prescribing | ||||
Oral tablet | |||||
Fosinopril sodium (Non-proprietary) | |||||
furosemide | Joint formulary choice | ||||
Oral solution | |||||
Furosemide (Non-proprietary) | Joint formulary choice | ||||
Frusol (Rosemont Pharmaceuticals Ltd) | Joint formulary choice | ||||
Solution for injection | |||||
Furosemide (Non-proprietary) | Hospital only | ||||
Oral tablet | |||||
Furosemide (Non-proprietary) | |||||
hydralazine hydrochloride | Specialist knowledge/initiation | ||||
Powder for solution for injection | |||||
Hydralazine hydrochloride (Non-proprietary) | |||||
Oral tablet | |||||
Hydralazine hydrochloride (Non-proprietary) | |||||
Apresoline (Advanz Pharma) | |||||
hydrochlorothiazide | Not approved for prescribing | ||||
imidapril hydrochloride | Not approved for prescribing | ||||
Oral tablet | |||||
Tanatril (Northumbria Pharma Ltd) | |||||
indapamide | Joint formulary choice | ||||
Modified-release tablet | |||||
Indapamide (Non-proprietary) | |||||
Alkapamid XL (HBS Healthcare Ltd) | Joint formulary choice | ||||
Cardide SR (Teva UK Ltd) | Joint formulary choice | ||||
Lorvacs XL (Torrent Pharma (UK) Ltd) | |||||
Natrilix SR (Servier Laboratories Ltd) | Joint formulary choice | ||||
Oral tablet | |||||
Indapamide (Non-proprietary) | |||||
Natrilix (Servier Laboratories Ltd) | |||||
indoramin | Not approved for prescribing | ||||
Oral tablet | |||||
Indoramin (Non-proprietary) | |||||
Doralese Tiltab (Essential Generics Ltd) | |||||
irbesartan | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Irbesartan (Non-proprietary) | |||||
Aprovel (Sanofi) | |||||
Ifirmasta (Krka UK Ltd) | |||||
irbesartan with hydrochlorothiazide | Not approved for prescribing | ||||
Oral tablet | |||||
Irbesartan with hydrochlorothiazide (Non-proprietary) | |||||
CoAprovel (Sanofi) | |||||
labetalol hydrochloride | Joint formulary choice | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Solution for injection | |||||
Labetalol hydrochloride (Non-proprietary) | Hospital only | ||||
Oral tablet | |||||
Labetalol hydrochloride (Non-proprietary) | |||||
Trandate (RPH Pharmaceuticals AB) | |||||
lacidipine | Not approved for prescribing | ||||
Oral tablet | |||||
Lacidipine (Non-proprietary) | |||||
Molap (Rivopharm (UK) Ltd) | |||||
Motens (GlaxoSmithKline UK Ltd) | |||||
lercanidipine hydrochloride | Not approved for prescribing | ||||
Oral tablet | |||||
Lercanidipine hydrochloride (Non-proprietary) | |||||
Zanidip (Recordati Pharmaceuticals Ltd) | |||||
lisinopril | Joint formulary choice | ||||
Oral solution | |||||
Lisinopril (Non-proprietary) | Joint formulary choice | ||||
Oral tablet | |||||
Lisinopril (Non-proprietary) | |||||
Zestril (Atnahs Pharma UK Ltd) | |||||
lisinopril with hydrochlorothiazide | Not approved for prescribing | ||||
Oral tablet | |||||
Lisinopril with hydrochlorothiazide (Non-proprietary) | |||||
Lisoretic (Bristol Laboratories Ltd) | |||||
Zestoretic (Atnahs Pharma UK Ltd) | |||||
losartan potassium | Joint formulary choice | ||||
Oral tablet | |||||
Losartan potassium (Non-proprietary) | |||||
Cozaar (Organon Pharma (UK) Ltd) | |||||
losartan with hydrochlorothiazide | Not approved for prescribing | ||||
Oral tablet | |||||
Losartan with hydrochlorothiazide (Non-proprietary) | |||||
Cozaar-Comp (Organon Pharma (UK) Ltd) | |||||
methyldopa | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Methyldopa (Non-proprietary) | |||||
metolazone | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Metolazone (Non-proprietary) | |||||
Xaqua (Renascience Pharma Ltd) | |||||
metoprolol tartrate | Joint formulary choice | ||||
Solution for injection | |||||
Betaloc (Recordati Pharmaceuticals Ltd) | Hospital only | ||||
Oral tablet | |||||
Metoprolol tartrate (Non-proprietary) | |||||
minoxidil | Specialist knowledge/initiation | ||||
Cutaneous solution | |||||
Regaine (Johnson & Johnson Ltd, McNeil Products Ltd) | |||||
Cutaneous foam | |||||
Regaine (McNeil Products Ltd) | |||||
Regaine for Women Once a Day (McNeil Products Ltd) | |||||
Oral tablet | |||||
Minoxidil (Non-proprietary) | |||||
Loniten (Pfizer Ltd) | |||||
moxonidine | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Moxonidine (Non-proprietary) | |||||
Physiotens (Viatris UK Healthcare Ltd) | |||||
nadolol | Not approved for prescribing | ||||
Oral tablet | |||||
Nadolol (Non-proprietary) | |||||
nebivolol | Not approved for prescribing | ||||
Oral tablet | |||||
Nebivolol (Non-proprietary) | |||||
Nebilet (A. Menarini Farmaceutica Internazionale SRL) | |||||
nicardipine hydrochloride | Not approved for prescribing | ||||
Solution for infusion | |||||
Nicardipine hydrochloride (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Oral capsule | |||||
Cardene (Laboratoire X.O) | |||||
nifedipine | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Modified-release tablet | |||||
Adalat LA (Bayer Plc) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Adanif XL (Advanz Pharma) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Adipine MR (Chiesi Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Adipine XL (Chiesi Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Dexipress MR (Dexcel-Pharma Ltd) | |||||
Fortipine LA (Advanz Pharma) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Neozipine XL (Kent Pharma (UK) Ltd) | |||||
Nifedipress MR (Dexcel-Pharma Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Tensipine MR (Genus Pharmaceuticals Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Valni Retard (Tillomed Laboratories Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Modified-release capsule | |||||
Coracten SR (Teofarma S.r.l.) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Coracten XL (Teofarma S.r.l.) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Oral drops | |||||
Nifedipine (Non-proprietary) | Not approved for prescribing | ||||
Oral capsule | |||||
Nifedipine (Non-proprietary) | |||||
olmesartan medoxomil | Not approved for prescribing | ||||
Oral tablet | |||||
Olmesartan medoxomil (Non-proprietary) | |||||
Olmetec (Daiichi Sankyo UK Ltd) | |||||
olmesartan with amlodipine | Not approved for prescribing | ||||
Oral tablet | |||||
Sevikar (Daiichi Sankyo UK Ltd) | |||||
olmesartan with amlodipine and hydrochlorothiazide | Specialist knowledge/initiation | ||||
Primary care prescribing of Sevikar HCT®
Sevikar HCT® (olmesartan with amlodipine and hydrochlorthiazide) can be prescribed for essential hypertension, provided that it is initiated by a specialist in secondary care for the following cohorts of patients who are non-compliant with triple therapy for hypertension prescribed as individual drug components:
Prescribing can be continued in primary care following specialist initiation once maintenance dose has been achieved. |
|||||
Oral tablet | |||||
Sevikar HCT (Daiichi Sankyo UK Ltd) | Specialist knowledge/initiation | ||||
olmesartan with hydrochlorothiazide | Not approved for prescribing | ||||
Oral tablet | |||||
Olmesartan with hydrochlorothiazide (Non-proprietary) | |||||
Olmetec Plus (Daiichi Sankyo UK Ltd) | |||||
perindopril arginine | Not approved for prescribing | ||||
Oral tablet | |||||
Coversyl Arginine (Servier Laboratories Ltd) | |||||
perindopril arginine with indapamide | Not approved for prescribing | ||||
Oral tablet | |||||
Coversyl Arginine Plus (Servier Laboratories Ltd) | |||||
perindopril erbumine | Joint formulary choice | ||||
Oral tablet | |||||
Perindopril erbumine (Non-proprietary) | |||||
perindopril erbumine with amlodipine | |||||
pindolol | Not approved for prescribing | ||||
prazosin | Not approved for prescribing | ||||
Oral tablet | |||||
Prazosin (Non-proprietary) | |||||
Hypovase (Pfizer Ltd) | |||||
propranolol hydrochloride | Specialist knowledge/initiation | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Modified-release capsule | |||||
Bedranol SR (Almus Pharmaceuticals Ltd, Sandoz Ltd) | Specialist knowledge/initiation | ||||
Beta-Prograne (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Half Beta-Prograne (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Oral solution | |||||
Propranolol hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Propranolol hydrochloride (Non-proprietary) | |||||
quinapril | Not approved for prescribing | ||||
Oral tablet | |||||
Quinapril (Non-proprietary) | |||||
Accupro (Pfizer Ltd) | |||||
quinapril with hydrochlorothiazide | Not approved for prescribing | ||||
Oral tablet | |||||
Accuretic (Pfizer Ltd) | |||||
ramipril | Joint formulary choice | ||||
Oral solution | |||||
Ramipril (Non-proprietary) | Joint formulary choice | ||||
Oral tablet | |||||
Ramipril (Non-proprietary) | |||||
Tritace (Sanofi) | |||||
Oral capsule | |||||
Ramipril (Non-proprietary) | |||||
ramipril with felodipine | Not approved for prescribing | ||||
spironolactone | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Spironolactone (Non-proprietary) | |||||
Aldactone (Pfizer Ltd) | |||||
telmisartan | Not approved for prescribing | ||||
Oral tablet | |||||
Telmisartan (Non-proprietary) | |||||
Micardis (Boehringer Ingelheim Ltd) | |||||
telmisartan with hydrochlorothiazide | Not approved for prescribing | ||||
Oral tablet | |||||
Telmisartan with hydrochlorothiazide (Non-proprietary) | |||||
MicardisPlus (Boehringer Ingelheim Ltd) | |||||
MicardisPlus 80/25 (Boehringer Ingelheim Ltd) | |||||
Tolucombi (Krka UK Ltd) | |||||
terazosin | Not approved for prescribing | ||||
Form unstated | |||||
Hytrin (Advanz Pharma) | Not approved for prescribing | ||||
Oral tablet | |||||
Terazosin (Non-proprietary) | |||||
Hytrin (Advanz Pharma) | |||||
timolol maleate | Not approved for prescribing | ||||
Eye drops | |||||
Timolol maleate (Non-proprietary) | |||||
Eysano (Aspire Pharma Ltd) | |||||
Timoptol (Santen UK Ltd) | |||||
Tiopex (Thea Pharmaceuticals Ltd) | |||||
Eye gel | |||||
Timoptol-LA (Santen UK Ltd) | |||||
Oral tablet | |||||
Timolol maleate (Non-proprietary) | |||||
timolol with bendroflumethiazide | Not approved for prescribing | ||||
Oral tablet | |||||
Timolol with bendroflumethiazide (Non-proprietary) | |||||
torasemide | Not approved for prescribing | ||||
Oral tablet | |||||
Torasemide (Non-proprietary) | |||||
Torem (Viatris UK Healthcare Ltd) | |||||
trandolapril | Not approved for prescribing | ||||
Oral capsule | |||||
Trandolapril (Non-proprietary) | |||||
triamterene with chlortalidone | Not approved for prescribing | ||||
Oral tablet | |||||
Triamterene with chlortalidone (Non-proprietary) | |||||
valsartan | Joint formulary choice | ||||
Oral solution | |||||
Diovan (Novartis Pharmaceuticals UK Ltd) | Joint formulary choice | ||||
Oral tablet | |||||
Valsartan (Non-proprietary) | |||||
Oral capsule | |||||
Valsartan (Non-proprietary) | |||||
valsartan with hydrochlorothiazide | Not approved for prescribing | ||||
Oral tablet | |||||
Valsartan with hydrochlorothiazide (Non-proprietary) | |||||
Co-Diovan (Novartis Pharmaceuticals UK Ltd) | |||||
verapamil hydrochloride | Specialist knowledge/initiation | ||||
Modified-release tablet | |||||
Half Securon (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
Securon SR (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
Verapamil for cluster headaches
Oral verapamil for cluster headaches should be prescribed under the explicit direction of a specialist only. |
|||||
Vera-Til SR (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Verapress MR (Dexcel-Pharma Ltd) | Specialist knowledge/initiation | ||||
Oral solution | |||||
Verapamil hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
Solution for injection | |||||
Securon (Viatris UK Healthcare Ltd) | Hospital only | ||||
Oral tablet | |||||
Verapamil hydrochloride (Non-proprietary) | |||||
xipamide | Not approved for prescribing | ||||
Oral tablet | |||||
Diurexan (Viatris UK Healthcare Ltd) | |||||
Cardiovascular system / Portal hypertension | |||||
carvedilol | |||||
Oral tablet | |||||
Carvedilol (Non-proprietary) | |||||
propranolol hydrochloride | Specialist knowledge/initiation | ||||
Modified-release capsule | |||||
Bedranol SR (Almus Pharmaceuticals Ltd, Sandoz Ltd) | Specialist knowledge/initiation | ||||
Beta-Prograne (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Half Beta-Prograne (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Oral solution | |||||
Propranolol hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Propranolol hydrochloride (Non-proprietary) | |||||
Cardiovascular system / Pulmonary hypertension | |||||
ambrisentan | Hospital only | ||||
Oral tablet | |||||
Ambrisentan (Non-proprietary) | |||||
Volibris (GlaxoSmithKline UK Ltd) | |||||
bosentan | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Oral tablet | |||||
Bosentan (Non-proprietary) | |||||
epoprostenol | Hospital only | ||||
Powder for solution for infusion | |||||
Epoprostenol (Non-proprietary) | |||||
Veletri (Janssen-Cilag Ltd) | |||||
Powder and solvent for solution for infusion | |||||
Flolan (GlaxoSmithKline UK Ltd) | Hospital only | ||||
iloprost | Hospital only | ||||
Solution for infusion | |||||
Iloprost (Non-proprietary) | |||||
Nebuliser liquid | |||||
Iloprost (Non-proprietary) | |||||
Ventavis (Bayer Plc) | |||||
macitentan | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Oral tablet | |||||
Opsumit (Janssen-Cilag Ltd) | |||||
riociguat | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Oral tablet | |||||
Adempas (Merck Sharp & Dohme (UK) Ltd) | |||||
selexipag | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Oral tablet | |||||
Uptravi (Janssen-Cilag Ltd) | |||||
sildenafil | Hospital only | ||||
Oral suspension | |||||
Sildenafil (Non-proprietary) | |||||
Revatio (Viatris UK Healthcare Ltd) | Hospital only | ||||
Solution for injection | |||||
Revatio (Viatris UK Healthcare Ltd) | Hospital only | ||||
Oral tablet | |||||
Sildenafil (Non-proprietary) | |||||
Granpidam (Accord-UK Ltd) | |||||
Revatio (Viatris UK Healthcare Ltd) | |||||
Viagra (Viatris UK Healthcare Ltd) | |||||
tadalafil | Hospital only | ||||
Oral tablet | |||||
Tadalafil (Non-proprietary) | |||||
Adcirca (Eli Lilly and Company Ltd) | |||||
Cialis (Eli Lilly and Company Ltd) | |||||
Talmanco (Viatris UK Healthcare Ltd) | |||||
treprostinil | |||||
Solution for infusion | |||||
Treprostinil (Non-proprietary) | |||||
Treposuvi (AOP Orphan Ltd) | |||||
Trepulmix (AOP Orphan Ltd) | |||||
Cardiovascular system / Hypertension associated with phaeochromocytoma | |||||
phenoxybenzamine hydrochloride | Not approved for prescribing | ||||
Oral capsule | |||||
Phenoxybenzamine hydrochloride (Non-proprietary) | |||||
propranolol hydrochloride | Specialist knowledge/initiation | ||||
Modified-release capsule | |||||
Bedranol SR (Almus Pharmaceuticals Ltd, Sandoz Ltd) | Specialist knowledge/initiation | ||||
Beta-Prograne (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Half Beta-Prograne (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Oral solution | |||||
Propranolol hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Propranolol hydrochloride (Non-proprietary) | |||||
Cardiovascular system / Hypertensive crises | |||||
hydralazine hydrochloride | Specialist knowledge/initiation | ||||
Powder for solution for injection | |||||
Hydralazine hydrochloride (Non-proprietary) | Hospital only | ||||
Oral tablet | |||||
Hydralazine hydrochloride (Non-proprietary) | |||||
Apresoline (Advanz Pharma) | |||||
labetalol hydrochloride | Hospital only | ||||
Solution for injection | |||||
Labetalol hydrochloride (Non-proprietary) | Hospital only | ||||
Oral tablet | |||||
Labetalol hydrochloride (Non-proprietary) | |||||
Trandate (RPH Pharmaceuticals AB) | |||||
sodium nitroprusside | Hospital only | ||||
Powder and solvent for solution for infusion | |||||
Sodium nitroprusside (Non-proprietary) | Hospital only | ||||
Cardiovascular system / Hypotension and shock | |||||
angiotensin II | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
Solution for infusion | |||||
Giapreza (PAION Deutschland GmbH) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
dobutamine | Hospital only | ||||
Solution for infusion | |||||
Dobutamine (Non-proprietary) | Hospital only | ||||
dopamine hydrochloride | Hospital only | ||||
Solution for infusion | |||||
Dopamine hydrochloride (Non-proprietary) | Hospital only | ||||
ephedrine hydrochloride | Hospital only | ||||
Solution for injection | |||||
Ephedrine hydrochloride (Non-proprietary) | Hospital only | ||||
Oral tablet | |||||
Ephedrine hydrochloride (Non-proprietary) | |||||
metaraminol | Hospital only | ||||
Solution for injection | |||||
Metaraminol (Non-proprietary) | Hospital only | ||||
midodrine hydrochloride | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Midodrine hydrochloride (Non-proprietary) | |||||
Bramox (Brancaster Pharma Ltd) | |||||
noradrenaline/norepinephrine | Hospital only | ||||
Solution for infusion | |||||
Noradrenaline/norepinephrine (Non-proprietary) | Hospital only | ||||
Sinora (Sandoz Ltd) | |||||
phenylephrine hydrochloride | Hospital only | ||||
Solution for injection | |||||
Phenylephrine hydrochloride (Non-proprietary) | Hospital only | ||||
Eye drops | |||||
Phenylephrine hydrochloride (Non-proprietary) | |||||
sodium nitroprusside | Hospital only | ||||
Powder and solvent for solution for infusion | |||||
Sodium nitroprusside (Non-proprietary) | Hospital only | ||||
Cardiovascular system / Vascular disease | |||||
cilostazol | Not approved for prescribing |
NICE TA223 |
|||
Oral tablet | |||||
Cilostazol (Non-proprietary) | |||||
iloprost | |||||
Solution for infusion | |||||
Iloprost (Non-proprietary) | |||||
Nebuliser liquid | |||||
Iloprost (Non-proprietary) | |||||
Ventavis (Bayer Plc) | |||||
inositol nicotinate | Not approved for prescribing |
NICE TA223 |
|||
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
Oral capsule | |||||
Inositol nicotinate (Non-proprietary) | |||||
naftidrofuryl oxalate | Specialist knowledge/initiation |
NICE TA223 |
|||
Oral capsule | |||||
Naftidrofuryl oxalate (Non-proprietary) | |||||
Praxilene (Merck Serono Ltd) | |||||
nifedipine | Joint formulary choice | ||||
Modified-release tablet | |||||
Adalat LA (Bayer Plc) | |||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Adanif XL (Advanz Pharma) | |||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Adipine MR (Chiesi Ltd) | |||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Adipine XL (Chiesi Ltd) | |||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Dexipress MR (Dexcel-Pharma Ltd) | |||||
Fortipine LA (Advanz Pharma) | |||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Neozipine XL (Kent Pharma (UK) Ltd) | |||||
Nifedipress MR (Dexcel-Pharma Ltd) | |||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Tensipine MR (Genus Pharmaceuticals Ltd) | |||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Valni Retard (Tillomed Laboratories Ltd) | |||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Modified-release capsule | |||||
Coracten SR (Teofarma S.r.l.) | |||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Coracten XL (Teofarma S.r.l.) | |||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Oral drops | |||||
Nifedipine (Non-proprietary) | Not approved for prescribing | ||||
Oral capsule | |||||
Nifedipine (Non-proprietary) | |||||
oxerutins | Not approved for prescribing | ||||
Oral capsule | |||||
Paroven (Thornton & Ross Ltd) | |||||
pentoxifylline | Not approved for prescribing |
NICE TA223 |
|||
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
Modified-release tablet | |||||
Trental (Neuraxpharm UK Ltd) | Not approved for prescribing | ||||
prazosin | Not approved for prescribing | ||||
Oral tablet | |||||
Prazosin (Non-proprietary) | |||||
Hypovase (Pfizer Ltd) | |||||
Cardiovascular system / Vein malformations | |||||
lauromacrogol 400 | |||||
Solution for injection | |||||
Lauromacrogol 400 (Non-proprietary) | |||||
Aethoxysklerol (Kora Healthcare) | |||||
sodium tetradecyl sulfate | Not approved for prescribing | ||||
Solution for injection | |||||
Fibro-Vein (STD Pharmaceutical Products Ltd) | Not approved for prescribing | ||||
Cardiovascular system / Cardiomyopathy | |||||
mavacamten | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA913 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
Oral capsule | |||||
Camzyos (Bristol-Myers Squibb Pharmaceuticals Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Cardiovascular system / Cardiac diagnostic procedures and surgeries | |||||
dobutamine | Hospital only | ||||
Solution for infusion | |||||
Dobutamine (Non-proprietary) | Hospital only | ||||
Cardiovascular system / Blocked catheters and lines | |||||
epoprostenol | Hospital only | ||||
Powder for solution for infusion | |||||
Epoprostenol (Non-proprietary) | |||||
Veletri (Janssen-Cilag Ltd) | |||||
Powder and solvent for solution for infusion | |||||
Flolan (GlaxoSmithKline UK Ltd) | Hospital only | ||||
heparin (unfractionated) | Hospital only | ||||
Solution for injection | |||||
Heparin (unfractionated) (Non-proprietary) | Hospital only | ||||
Infusion | |||||
Heparin (unfractionated) (Non-proprietary) | Hospital only | ||||
Form unstated | |||||
Heparin (unfractionated) (Non-proprietary) | Hospital only | ||||
urokinase | Hospital only | ||||
Powder for solution for injection | |||||
Syner-KINASE (Syner-Med (Pharmaceutical Products) Ltd) | Hospital only | ||||
Cardiovascular system / Thromboembolism | |||||
acenocoumarol | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Sinthrome (Norgine Pharmaceuticals Ltd) | |||||
alteplase | Hospital only |
NICE TA264 |
|||
Powder and solvent for solution for injection | |||||
Actilyse (Boehringer Ingelheim Ltd) | Hospital only | ||||
Powder and solvent for solution for infusion | |||||
Actilyse (Boehringer Ingelheim Ltd) | Hospital only | ||||
andexanet alfa | Hospital only |
NICE TA697 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Powder for solution for infusion | |||||
Ondexxya (AstraZeneca UK Ltd) | Hospital only | ||||
apixaban | Specialist knowledge/initiation |
NICE TA245 NICE TA275 NICE TA341 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Change of formulary status from Amber (shared care) to Amber (specialist knowledge/initiation)
February 2020 - the Joint Prescribing Group (JPG) agreed to approve the change of formulary status for apixaban, dabigatran, edoxaban and rivaroxaban from Amber (shared care) to Amber (specialist knowledge/initiation) as these drugs are now commonly initiated in primary care. 'Transfer of care' documents are still available to provide prescribing and monitoring guidance for these drugs. |
|||||
Oral tablet | |||||
Apixaban (Non-proprietary) | |||||
Eliquis (Bristol-Myers Squibb Pharmaceuticals Ltd) | |||||
argatroban monohydrate | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Solution for infusion | |||||
Argatroban monohydrate (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Exembol (Mitsubishi Tanabe Pharma Europe Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
aspirin | Joint formulary choice | ||||
Dispersible tablet | |||||
Aspirin (Non-proprietary) | |||||
Disprin (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
Gastro-resistant tablet | |||||
Aspirin (Non-proprietary) | Joint formulary choice | ||||
Nu-Seals (Alliance Pharmaceuticals Ltd) | |||||
Suppository | |||||
Aspirin (Non-proprietary) | |||||
Oral tablet | |||||
Aspirin (Non-proprietary) | |||||
bemiparin sodium | |||||
bivalirudin | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
Powder for solution for infusion | |||||
Bivalirudin (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
clopidogrel | Joint formulary choice |
NICE TA210 |
|||
Oral tablet | |||||
Clopidogrel (Non-proprietary) | |||||
Plavix (Sanofi) | |||||
dabigatran etexilate | Specialist knowledge/initiation |
NICE TA157 NICE TA249 NICE TA327 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Change of formulary status from Amber (shared care) to Amber (specialist knowledge/initiation)
February 2020 - the Joint Prescribing Group (JPG) agreed to approve the change of formulary status for apixaban, dabigatran, edoxaban and rivaroxaban from Amber (shared care) to Amber (specialist knowledge/initiation) as these drugs are now commonly initiated in primary care. 'Transfer of care' documents are still available to provide prescribing and monitoring guidance for these drugs. |
|||||
Oral capsule | |||||
Dabigatran etexilate (Non-proprietary) | |||||
Pradaxa (Boehringer Ingelheim Ltd) | |||||
dalteparin sodium | Hospital only | ||||
Thromboprophylaxis
June 2020 - the JPG agreed to approve the addition of dalteparin to the joint formulary. Dalteparin should only be used in line with HUHFT policy on Thromboprophylaxis and treatment of VTE complications in COVID-19 infection. |
|||||
Solution for injection | |||||
Fragmin (Pfizer Ltd) | Not approved for prescribing | ||||
danaparoid sodium | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Solution for injection | |||||
Danaparoid sodium (Non-proprietary) | Not approved for prescribing | ||||
dipyridamole | Joint formulary choice |
NICE TA210 |
|||
Modified-release capsule | |||||
Dipyridamole (Non-proprietary) | |||||
Attia (Dr Reddy's Laboratories (UK) Ltd) | Joint formulary choice | ||||
Oral suspension | |||||
Dipyridamole (Non-proprietary) | Joint formulary choice | ||||
Oral tablet | |||||
Dipyridamole (Non-proprietary) | |||||
edoxaban | Specialist knowledge/initiation |
NICE TA354 NICE TA355 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Change of formulary status from Amber (shared care) to Amber (specialist knowledge/initiation)
February 2020 - the Joint Prescribing Group (JPG) agreed to approve the change of formulary status for apixaban, dabigatran, edoxaban and rivaroxaban from Amber (shared care) to Amber (specialist knowledge/initiation) as these drugs are now commonly initiated in primary care. 'Transfer of care' documents are still available to provide prescribing and monitoring guidance for these drugs. |
|||||
Edoxaban is first line oral anticoagulant for atrial fibrillation
Edoxaban should be considered as the first line oral anticoagulant for stroke prevention in patients with atrial fibrillation. This is in line with guidance from NHSEI. |
|||||
Oral tablet | |||||
Lixiana (Daiichi Sankyo UK Ltd) | |||||
enoxaparin sodium | Shared care guideline | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
Solution for injection | |||||
Arovi (ROVI Biotech Ltd) | |||||
Clexane (Sanofi) | Shared care guideline | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
Inhixa (Techdow Pharma England Ltd) | Shared care guideline | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
Ledraxen (Tetris Pharma Ltd) | |||||
fondaparinux sodium | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Fondaparinux for the management of acute coronary syndrome
Indications: unstable angina, Suspected acute non ST Elevation MI (NSTEMI), Troponin +ve ACS and ST Elevation MI (STEMI) in patients receiving thrombolysis. |
|||||
Solution for injection | |||||
Fondaparinux sodium (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Arixtra (Viatris UK Healthcare Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
heparin (unfractionated) | Hospital only | ||||
Solution for injection | |||||
Heparin (unfractionated) (Non-proprietary) | Hospital only | ||||
Infusion | |||||
Heparin (unfractionated) (Non-proprietary) | Hospital only | ||||
Form unstated | |||||
Heparin (unfractionated) (Non-proprietary) | Hospital only | ||||
idarucizumab | Hospital only | ||||
Solution for infusion | |||||
Praxbind (Boehringer Ingelheim Ltd) | Hospital only | ||||
phenindione | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Phenindione (Non-proprietary) | |||||
prasugrel | Specialist knowledge/initiation |
NICE TA317 |
|||
Oral tablet | |||||
Prasugrel (Non-proprietary) | |||||
Efient (Vygoris Ltd) | |||||
rivaroxaban | Specialist knowledge/initiation |
NICE TA170 NICE TA256 NICE TA261 NICE TA287 NICE TA335 NICE TA607 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Change of formulary status from Amber (shared care) to Amber (specialist knowledge/initiation)
February 2020 - the Joint Prescribing Group (JPG) agreed to approve the change of formulary status for apixaban, dabigatran, edoxaban and rivaroxaban from Amber (shared care) to Amber (specialist knowledge/initiation) as these drugs are now commonly initiated in primary care. 'Transfer of care' documents are still available to provide prescribing and monitoring guidance for these drugs. |
|||||
Oral tablet | |||||
Rivaroxaban (Non-proprietary) | |||||
Xarelto (Bayer Plc) | |||||
streptokinase | Hospital only | ||||
Powder for solution for infusion | |||||
Streptokinase (Non-proprietary) | |||||
ticagrelor |
NICE TA236 NICE TA420 |
||||
Orodispersible tablet | |||||
Brilique (AstraZeneca UK Ltd) | |||||
Oral tablet | |||||
Brilique (AstraZeneca UK Ltd) | |||||
tinzaparin sodium | Hospital only | ||||
Solution for injection | |||||
Tinzaparin sodium (Non-proprietary) | Hospital only | ||||
urokinase | Hospital only | ||||
Powder for solution for injection | |||||
Syner-KINASE (Syner-Med (Pharmaceutical Products) Ltd) | Hospital only | ||||
warfarin sodium | Specialist knowledge/initiation | ||||
Oral suspension | |||||
Warfarin sodium (Non-proprietary) | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Warfarin sodium (Non-proprietary) | |||||
Cardiovascular system / Oedema | |||||
amiloride hydrochloride | Joint formulary choice | ||||
Oral solution | |||||
Amiloride hydrochloride (Non-proprietary) | Joint formulary choice | ||||
Oral tablet | |||||
Amiloride hydrochloride (Non-proprietary) | |||||
amiloride with bumetanide | Not approved for prescribing | ||||
Oral tablet | |||||
Amiloride with bumetanide (Non-proprietary) | |||||
bumetanide | Joint formulary choice | ||||
Oral solution | |||||
Bumetanide (Non-proprietary) | Joint formulary choice | ||||
Oral tablet | |||||
Bumetanide (Non-proprietary) | |||||
chlortalidone | Joint formulary choice | ||||
Oral tablet | |||||
Chlortalidone (Non-proprietary) | |||||
Hylaton (Morningside Healthcare Ltd) | |||||
co-amilofruse | Not approved for prescribing | ||||
Oral tablet | |||||
Co-amilofruse (Non-proprietary) | |||||
Frumil (Sanofi) | |||||
diamorphine hydrochloride | Hospital only | ||||
Powder for solution for injection | |||||
Diamorphine hydrochloride (Non-proprietary) | Hospital only | ||||
furosemide | Joint formulary choice | ||||
Oral solution | |||||
Furosemide (Non-proprietary) | Joint formulary choice | ||||
Frusol (Rosemont Pharmaceuticals Ltd) | Joint formulary choice | ||||
Solution for injection | |||||
Furosemide (Non-proprietary) | Hospital only | ||||
Oral tablet | |||||
Furosemide (Non-proprietary) | |||||
furosemide with triamterene | Not approved for prescribing | ||||
mannitol | Hospital only |
NICE TA266 |
|||
Infusion | |||||
Mannitol (Non-proprietary) | Hospital only | ||||
Inhalation powder | |||||
Mannitol (Non-proprietary) | Hospital only | ||||
Bronchitol (Chiesi Ltd) | Hospital only | ||||
metolazone | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Metolazone (Non-proprietary) | |||||
Xaqua (Renascience Pharma Ltd) | |||||
spironolactone with furosemide | Not approved for prescribing | ||||
torasemide | Not approved for prescribing | ||||
Oral tablet | |||||
Torasemide (Non-proprietary) | |||||
Torem (Viatris UK Healthcare Ltd) | |||||
triamterene | Not approved for prescribing | ||||
triamterene with chlortalidone | Not approved for prescribing | ||||
Oral tablet | |||||
Triamterene with chlortalidone (Non-proprietary) | |||||
xipamide | Not approved for prescribing | ||||
Oral tablet | |||||
Diurexan (Viatris UK Healthcare Ltd) | |||||
Cardiovascular system / Ascites | |||||
chlortalidone | Joint formulary choice | ||||
Oral tablet | |||||
Chlortalidone (Non-proprietary) | |||||
Hylaton (Morningside Healthcare Ltd) | |||||
co-amilozide | Not approved for prescribing | ||||
Oral tablet | |||||
Co-amilozide (Non-proprietary) | |||||
spironolactone | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Spironolactone (Non-proprietary) | |||||
Aldactone (Pfizer Ltd) | |||||
Cardiovascular system / Hyperlipidaemia | |||||
acipimox | Not approved for prescribing | ||||
Oral capsule | |||||
Olbetam (Pfizer Ltd) | |||||
alirocumab | Hospital only |
NICE TA393 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Solution for injection | |||||
Praluent (Sanofi) | Hospital only | ||||
atorvastatin | Joint formulary choice | ||||
Chewable tablet | |||||
Lipitor (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
Oral suspension | |||||
Atorvastatin (Non-proprietary) | |||||
Oral tablet | |||||
Atorvastatin (Non-proprietary) | |||||
Lipitor (Viatris UK Healthcare Ltd) | |||||
bempedoic acid | Specialist knowledge/initiation |
NICE TA694 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Oral tablet | |||||
Nilemdo (Daiichi Sankyo UK Ltd) | |||||
bempedoic acid with ezetimibe | Specialist knowledge/initiation |
NICE TA694 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Oral tablet | |||||
Nustendi (Daiichi Sankyo UK Ltd) | |||||
bezafibrate | Joint formulary choice | ||||
Modified-release tablet | |||||
Bezalip Mono (Teva UK Ltd) | Joint formulary choice | ||||
Lipozate (Noumed Life Sciences Ltd) | |||||
Oral tablet | |||||
Bezafibrate (Non-proprietary) | |||||
Bezalip (Teva UK Ltd) | |||||
ciprofibrate | Not approved for prescribing | ||||
Oral tablet | |||||
Ciprofibrate (Non-proprietary) | |||||
colesevelam hydrochloride | Not approved for prescribing | ||||
Oral tablet | |||||
Colesevelam hydrochloride (Non-proprietary) | |||||
Cholestagel (Neon Healthcare Ltd) | |||||
colestipol hydrochloride | Not approved for prescribing | ||||
Oral tablet | |||||
Colestipol hydrochloride (Non-proprietary) | |||||
colestyramine | Not approved for prescribing | ||||
Powder for oral suspension | |||||
Colestyramine (Non-proprietary) | |||||
Questran (Neon Healthcare Ltd) | |||||
Questran Light (Neon Healthcare Ltd) | |||||
evinacumab | |||||
Solution for infusion | |||||
Evkeeza (Ultragenyx UK Ltd) | |||||
evolocumab | Hospital only |
NICE TA394 |
|||
Solution for injection | |||||
Repatha SureClick (Amgen Ltd) | Hospital only | ||||
ezetimibe | Joint formulary choice |
NICE TA385 |
|||
Oral tablet | |||||
Ezetimibe (Non-proprietary) | |||||
Ezetrol (Organon Pharma (UK) Ltd) | |||||
fenofibrate | Not approved for prescribing | ||||
Oral tablet | |||||
Fenofibrate (Non-proprietary) | |||||
Supralip (Viatris UK Healthcare Ltd) | |||||
Oral capsule | |||||
Fenofibrate (Non-proprietary) | |||||
Lipantil Micro (Viatris UK Healthcare Ltd) | |||||
fluvastatin | Not approved for prescribing | ||||
Modified-release tablet | |||||
Fluvastatin (Non-proprietary) | |||||
Oral capsule | |||||
Fluvastatin (Non-proprietary) | |||||
gemfibrozil | Not approved for prescribing | ||||
Oral tablet | |||||
Gemfibrozil (Non-proprietary) | |||||
Lopid (Pfizer Ltd) | |||||
Oral capsule | |||||
Lopid (Pfizer Ltd) | |||||
icosapent ethyl | Joint formulary choice |
NICE TA805 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Icosapent ethyl initiation in primary care
Initiation of icosapent ethyl in primary would be subject to availability of primary care guidance and patient information leaflet - in progress. Please note the North East London primary care prescribing pathway and patient information leaflet for icosapent ethyl are currently under development. Primary care prescribers are advised to wait for the prescribing pathway and patient information leaflet to be finalised prior to initiating icosapent ethyl in line with NICE TA805. |
|||||
Oral capsule | |||||
Vazkepa (Amarin Pharmaceuticals Ireland Ltd) | Joint formulary choice | ||||
inclisiran | Joint formulary choice |
NICE TA733 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Inclisiran prescribing in primary care
Please note the North East London primary care prescribing pathway, including training resources for primary care prescribers are currently under development. Primary care prescribers are advised to wait for the prescribing pathway and training to be finalised prior to initiating inclisiran in line with NICE TA733 |
|||||
Solution for injection | |||||
Leqvio (Novartis Pharmaceuticals UK Ltd) | Joint formulary choice | ||||
Inclisiran prescribing in primary care
Please note the North East London primary care prescribing pathway, including training resources for primary care prescribers are currently under development. Primary care prescribers are advised to wait for the prescribing pathway and training to be finalised prior to initiating inclisiran in line with NICE TA733 |
|||||
lomitapide | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Oral capsule | |||||
Lojuxta (Chiesi Ltd) | |||||
nicotinic acid | Not approved for prescribing | ||||
Oral capsule | |||||
Nicotinic acid (Non-proprietary) | |||||
omega-3-acid ethyl esters | Not approved for prescribing | ||||
Oral capsule | |||||
Omega-3-acid ethyl esters (Non-proprietary) | |||||
A1 Omega (TriOn Pharma Ltd) | |||||
AceOmeg (Essential-Healthcare Ltd) | |||||
Teromeg (Advanz Pharma) | |||||
pravastatin sodium | Joint formulary choice | ||||
Oral tablet | |||||
Pravastatin sodium (Non-proprietary) | |||||
rosuvastatin | Not approved for prescribing | ||||
Oral tablet | |||||
Rosuvastatin (Non-proprietary) | |||||
Crestor (AstraZeneca UK Ltd) | |||||
Oral capsule | |||||
Rosuvastatin (Non-proprietary) | |||||
simvastatin | Joint formulary choice | ||||
Oral suspension | |||||
Simvastatin (Non-proprietary) | Joint formulary choice | ||||
Oral tablet | |||||
Simvastatin (Non-proprietary) | |||||
Zocor (Organon Pharma (UK) Ltd) | |||||
simvastatin with ezetimibe | Not approved for prescribing | ||||
Oral tablet | |||||
Simvastatin with ezetimibe (Non-proprietary) | |||||
Inegy (Organon Pharma (UK) Ltd) | |||||
volanesorsen |
NICE HST13 |
||||
Solution for injection | |||||
Waylivra (Swedish Orphan Biovitrum Ltd) | |||||
Cardiovascular system / Bleeding disorders | |||||
emicizumab | Not approved for prescribing | ||||
Solution for injection | |||||
Hemlibra (Roche Products Ltd) | Not approved for prescribing | ||||
tranexamic acid | Joint formulary choice | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Solution for injection | |||||
Tranexamic acid (Non-proprietary) | Hospital only | ||||
Cyklokapron (Pfizer Ltd) | Hospital only | ||||
Oral tablet | |||||
Tranexamic acid (Non-proprietary) | |||||
Cyklokapron (Viatris UK Healthcare Ltd) | |||||
Cardiovascular system / Coagulation factor deficiencies | |||||
dried prothrombin complex | Not approved for prescribing | ||||
Powder and solvent for solution for injection | |||||
Beriplex P/N (CSL Behring UK Ltd) | |||||
Powder and solvent for solution for infusion | |||||
Octaplex (Octapharma Ltd) | |||||
factor IX [Specialist drug] | Not approved for prescribing | ||||
Powder and solvent for solution for injection | |||||
Alprolix (Swedish Orphan Biovitrum Ltd) | |||||
Haemonine (Grifols UK Ltd) | Not approved for prescribing | ||||
Idelvion (CSL Behring UK Ltd) | |||||
Refixia (Novo Nordisk Ltd) | |||||
Replenine-VF (Bio Products Laboratory Ltd) | Not approved for prescribing | ||||
Rixubis (Takeda UK Ltd) | |||||
Powder and solvent for solution for infusion | |||||
BeneFIX (Pfizer Ltd) | Not approved for prescribing | ||||
factor VIII fraction, dried [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Powder and solvent for solution for injection | |||||
Factor VIII fraction, dried (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Advate (Takeda UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Adynovi (Takeda UK Ltd) | |||||
Elocta (Swedish Orphan Biovitrum Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Esperoct (Novo Nordisk Ltd) | |||||
Haemoctin (Grifols UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
NovoEight (Novo Nordisk Ltd) | |||||
Nuwiq (Octapharma Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Obizur (Takeda UK Ltd) | |||||
Octanate LV (Octapharma Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
ReFacto (Pfizer Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Voncento (CSL Behring UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Powder and solvent for solution for infusion | |||||
Advate (Takeda UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Wilate 1000 (Octapharma Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Wilate 500 (Octapharma Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
factor VIII inhibitor bypassing fraction [Specialist drug] | Not approved for prescribing | ||||
Powder and solvent for solution for infusion | |||||
FEIBA Imuno (Takeda UK Ltd) | Not approved for prescribing | ||||
factor VIIa (recombinant) | Hospital only | ||||
Powder and solvent for solution for injection | |||||
Cevenfacta (LFB Biopharmaceuticals Ltd) | |||||
NovoSeven (Novo Nordisk Ltd) | Hospital only | ||||
factor XIII A-subunit (recombinant) [Specialist drug] | |||||
Powder and solvent for solution for injection | |||||
NovoThirteen (Novo Nordisk Ltd) | |||||
factor XIII fraction, dried [Specialist drug] | Not approved for prescribing | ||||
Powder and solvent for solution for injection | |||||
Fibrogammin P (CSL Behring UK Ltd) | Not approved for prescribing | ||||
fibrinogen, dried [Specialist drug] | Not approved for prescribing | ||||
Powder for solution for infusion | |||||
Riastap (CSL Behring UK Ltd) | |||||
Powder and solvent for solution for infusion | |||||
FibCLOT (LFB Biopharmaceuticals Ltd) | |||||
Fibryga (Octapharma Ltd) | |||||
fresh frozen plasma | Hospital only | ||||
Infusion | |||||
OctaplasLG (Octapharma Ltd) | |||||
protein C concentrate [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Powder and solvent for solution for injection | |||||
Ceprotin (Takeda UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
von Willebrand factor [Specialist drug] | |||||
Powder and solvent for solution for injection | |||||
Veyvondi (Takeda UK Ltd) | |||||
Willfact (LFB Biopharmaceuticals Ltd) | |||||
Cardiovascular system / Subarachnoid haemorrhage | |||||
nimodipine | Hospital only | ||||
Solution for infusion | |||||
Nimotop (Bayer Plc) | Hospital only | ||||
Oral tablet | |||||
Nimotop (Bayer Plc) | |||||
Cardiovascular system / Heart failure | |||||
bendroflumethiazide | Not approved for prescribing | ||||
Oral tablet | |||||
Bendroflumethiazide (Non-proprietary) | |||||
bisoprolol fumarate | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Bisoprolol fumarate (Non-proprietary) | |||||
Cardicor (Merck Serono Ltd) | |||||
candesartan cilexetil | Joint formulary choice | ||||
Oral tablet | |||||
Candesartan cilexetil (Non-proprietary) | |||||
Amias (Neon Healthcare Ltd) | |||||
captopril | Not approved for prescribing | ||||
Oral solution | |||||
Captopril (Non-proprietary) | Not approved for prescribing | ||||
Oral tablet | |||||
Captopril (Non-proprietary) | |||||
chlortalidone | Joint formulary choice | ||||
Oral tablet | |||||
Chlortalidone (Non-proprietary) | |||||
Hylaton (Morningside Healthcare Ltd) | |||||
co-amilozide | Not approved for prescribing | ||||
Oral tablet | |||||
Co-amilozide (Non-proprietary) | |||||
co-flumactone | Not approved for prescribing | ||||
dapagliflozin | Specialist knowledge/initiation |
NICE TA288 NICE TA390 NICE TA418 NICE TA679 NICE TA902 NICE TA775 |
|||
Dapagliflozin and empagliflozin for heart failure
Dapagliflozin and empagliflozin for heart failure should only be initiated by or on recommendation of a specialist. |
|||||
Oral tablet | |||||
Forxiga (AstraZeneca UK Ltd) | Specialist knowledge/initiation | ||||
digoxin | Specialist knowledge/initiation | ||||
Oral solution | |||||
Digoxin (Non-proprietary) | |||||
Solution for injection | |||||
Digoxin (Non-proprietary) | Hospital only | ||||
Solution for infusion | |||||
Digoxin (Non-proprietary) | |||||
Oral tablet | |||||
Digoxin (Non-proprietary) | |||||
empagliflozin | Specialist knowledge/initiation |
NICE TA390 NICE TA336 NICE TA773 NICE TA929 NICE TA942 |
|||
Dapagliflozin and empagliflozin for heart failure
Dapagliflozin and empagliflozin for heart failure should only be initiated by or on recommendation of a specialist. |
|||||
Oral tablet | |||||
Jardiance (Boehringer Ingelheim Ltd) | Specialist knowledge/initiation | ||||
enalapril maleate | Joint formulary choice | ||||
Oral solution | |||||
Enalapril maleate (Non-proprietary) | |||||
Oral tablet | |||||
Enalapril maleate (Non-proprietary) | |||||
Innovace (Organon Pharma (UK) Ltd) | |||||
enoximone | Hospital only | ||||
Solution for injection | |||||
Perfan (Macure Pharma UK Ltd) | Hospital only | ||||
eplerenone | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Eplerenone (Non-proprietary) | |||||
Inspra (Viatris UK Healthcare Ltd) | |||||
fosinopril sodium | Not approved for prescribing | ||||
Oral tablet | |||||
Fosinopril sodium (Non-proprietary) | |||||
glyceryl trinitrate | Hospital only | ||||
Sublingual tablet | |||||
Glyceryl trinitrate (Non-proprietary) | |||||
Sublingual spray | |||||
Glyceryl trinitrate (Non-proprietary) | |||||
Nitrolingual (Beaumont Pharma Ltd) | |||||
Solution for infusion | |||||
Glyceryl trinitrate (Non-proprietary) | |||||
Nitronal (Beaumont Pharma Ltd) | |||||
Transdermal patch | |||||
Deponit (Forum Health Products Ltd) | |||||
Minitran (Viatris UK Healthcare Ltd) | |||||
Rectal ointment | |||||
Rectogesic (Kyowa Kirin International UK NewCo Ltd) | |||||
hydralazine hydrochloride | Specialist knowledge/initiation | ||||
Powder for solution for injection | |||||
Hydralazine hydrochloride (Non-proprietary) | |||||
Oral tablet | |||||
Hydralazine hydrochloride (Non-proprietary) | |||||
Apresoline (Advanz Pharma) | |||||
isosorbide dinitrate | Not approved for prescribing | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Modified-release tablet | |||||
Isoket Retard (Forum Health Products Ltd) | Not approved for prescribing | ||||
Solution for injection | |||||
Isosorbide dinitrate (Non-proprietary) | Hospital only | ||||
Isoket (Forum Health Products Ltd) | Hospital only | ||||
Solution for infusion | |||||
Isosorbide dinitrate (Non-proprietary) | Hospital only | ||||
Oral tablet | |||||
Isosorbide dinitrate (Non-proprietary) | |||||
isosorbide mononitrate | Joint formulary choice | ||||
Modified-release tablet | |||||
Isotard XL (Evolan Pharma AB) | Joint formulary choice | ||||
Modisal XL (Ennogen Pharma Ltd) | Joint formulary choice | ||||
Relosorb XL (Relonchem Ltd) | Joint formulary choice | ||||
Xismox XL (Genus Pharmaceuticals Ltd) | Joint formulary choice | ||||
Modified-release capsule | |||||
Elantan LA (Forum Health Products Ltd) | Joint formulary choice | ||||
Isodur XL (Galen Ltd) | Joint formulary choice | ||||
Monomax SR (Martindale Pharmaceuticals Ltd) | Joint formulary choice | ||||
Oral tablet | |||||
Isosorbide mononitrate (Non-proprietary) | |||||
ivabradine | Specialist knowledge/initiation |
NICE TA267 |
|||
Oral tablet | |||||
Ivabradine (Non-proprietary) | |||||
Procoralan (Servier Laboratories Ltd) | |||||
lisinopril | Joint formulary choice | ||||
Oral solution | |||||
Lisinopril (Non-proprietary) | Joint formulary choice | ||||
Oral tablet | |||||
Lisinopril (Non-proprietary) | |||||
Zestril (Atnahs Pharma UK Ltd) | |||||
losartan potassium | Joint formulary choice | ||||
Oral tablet | |||||
Losartan potassium (Non-proprietary) | |||||
Cozaar (Organon Pharma (UK) Ltd) | |||||
milrinone | Hospital only | ||||
Solution for injection | |||||
Milrinone (Non-proprietary) | |||||
Solution for infusion | |||||
Milrinone (Non-proprietary) | Hospital only | ||||
Primacor (Sanofi) | |||||
nebivolol | Not approved for prescribing | ||||
Oral tablet | |||||
Nebivolol (Non-proprietary) | |||||
Nebilet (A. Menarini Farmaceutica Internazionale SRL) | |||||
perindopril arginine | Not approved for prescribing | ||||
Oral tablet | |||||
Coversyl Arginine (Servier Laboratories Ltd) | |||||
perindopril erbumine | Joint formulary choice | ||||
Oral tablet | |||||
Perindopril erbumine (Non-proprietary) | |||||
prazosin | Not approved for prescribing | ||||
Oral tablet | |||||
Prazosin (Non-proprietary) | |||||
Hypovase (Pfizer Ltd) | |||||
quinapril | Not approved for prescribing | ||||
Oral tablet | |||||
Quinapril (Non-proprietary) | |||||
Accupro (Pfizer Ltd) | |||||
ramipril | Joint formulary choice | ||||
Oral solution | |||||
Ramipril (Non-proprietary) | Joint formulary choice | ||||
Oral tablet | |||||
Ramipril (Non-proprietary) | |||||
Tritace (Sanofi) | |||||
Oral capsule | |||||
Ramipril (Non-proprietary) | |||||
sacubitril with valsartan | Specialist knowledge/initiation |
NICE TA388 |
|||
Initiation and continuation of sacubitril valsartan (Entresto®)
Initiation of sacubitril valsartan (Entresto®) is to be undertaken under the direction of a consultant (cardiologist) with an established expertise in managing patients with heart failure and access to a multidisciplinary team. Sacubitril valsartan (Entresto®) can be continued in primary care following titration to optimum tolerated dose. |
|||||
Oral tablet | |||||
Entresto (Novartis Pharmaceuticals UK Ltd) | |||||
sodium nitroprusside | Hospital only | ||||
Powder and solvent for solution for infusion | |||||
Sodium nitroprusside (Non-proprietary) | Hospital only | ||||
spironolactone | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Spironolactone (Non-proprietary) | |||||
Aldactone (Pfizer Ltd) | |||||
valsartan | Joint formulary choice | ||||
Oral solution | |||||
Diovan (Novartis Pharmaceuticals UK Ltd) | Joint formulary choice | ||||
Oral tablet | |||||
Valsartan (Non-proprietary) | |||||
Oral capsule | |||||
Valsartan (Non-proprietary) | |||||
vericiguat | Not approved for prescribing | ||||
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
Oral tablet | |||||
Verquvo (Bayer Plc) | |||||
Cardiovascular system / Myocardial ischaemia | |||||
acebutolol | Not approved for prescribing | ||||
Oral tablet | |||||
Acebutolol (Non-proprietary) | |||||
amlodipine | Joint formulary choice | ||||
Oral suspension | |||||
Amlodipine (Non-proprietary) | |||||
Oral solution | |||||
Amlodipine (Non-proprietary) | Not approved for prescribing | ||||
Oral tablet | |||||
Amlodipine (Non-proprietary) | |||||
Istin (Viatris UK Healthcare Ltd) | |||||
aspirin | Joint formulary choice | ||||
Dispersible tablet | |||||
Aspirin (Non-proprietary) | |||||
Disprin (Reckitt Benckiser Healthcare (UK) Ltd) | |||||
Gastro-resistant tablet | |||||
Aspirin (Non-proprietary) | Joint formulary choice | ||||
Nu-Seals (Alliance Pharmaceuticals Ltd) | |||||
Suppository | |||||
Aspirin (Non-proprietary) | |||||
Oral tablet | |||||
Aspirin (Non-proprietary) | |||||
atenolol | Joint formulary choice | ||||
Oral solution | |||||
Atenolol (Non-proprietary) | Joint formulary choice | ||||
Solution for injection | |||||
Tenormin (Atnahs Pharma UK Ltd) | Hospital only | ||||
Oral tablet | |||||
Atenolol (Non-proprietary) | |||||
Tenormin (Atnahs Pharma UK Ltd) | |||||
bisoprolol fumarate | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Bisoprolol fumarate (Non-proprietary) | |||||
Cardicor (Merck Serono Ltd) | |||||
bivalirudin | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
Powder for solution for infusion | |||||
Bivalirudin (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
cangrelor | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Powder for solution for injection | |||||
Kengrexal (Chiesi Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
carvedilol | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Carvedilol (Non-proprietary) | |||||
diltiazem hydrochloride | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Modified-release tablet | |||||
Diltiazem hydrochloride (Non-proprietary) | Joint formulary choice | ||||
Retalzem (Kent Pharma (UK) Ltd) | Joint formulary choice | ||||
Tildiem (Sanofi) | Joint formulary choice | ||||
Tildiem Retard (Sanofi) | Joint formulary choice | ||||
Zeyam (Ennogen Pharma Ltd) | |||||
Modified-release capsule | |||||
Adizem-SR (Napp Pharmaceuticals Ltd) | Joint formulary choice | ||||
Adizem-XL (Napp Pharmaceuticals Ltd) | Joint formulary choice | ||||
Angitil SR (Ethypharm UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Angitil XL (Ethypharm UK Ltd) | Joint formulary choice | ||||
Slozem (Zentiva Pharma UK Ltd) | Joint formulary choice | ||||
Tildiem LA (Sanofi) | Joint formulary choice | ||||
Viazem XL (Thornton & Ross Ltd) | Joint formulary choice | ||||
Zemtard XL (Galen Ltd) | Joint formulary choice | ||||
eptifibatide | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Solution for injection | |||||
Eptifibatide (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Solution for infusion | |||||
Eptifibatide (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
felodipine | Not approved for prescribing | ||||
Modified-release tablet | |||||
Cardioplen XL (Chiesi Ltd) | Not approved for prescribing | ||||
Delofine XL (Morningside Healthcare Ltd) | |||||
Felendil XL (Teva UK Ltd) | Not approved for prescribing | ||||
Felotens XL (Thornton & Ross Ltd) | |||||
Neofel XL (Kent Pharma (UK) Ltd) | |||||
Parmid XL (Sandoz Ltd) | Not approved for prescribing | ||||
Pinefeld XL (Tillomed Laboratories Ltd) | |||||
Vascalpha (Accord-UK Ltd) | Not approved for prescribing | ||||
fondaparinux sodium | Hospital only | ||||
Fondaparinux for the management of acute coronary syndrome
Indications: unstable angina, Suspected acute non ST Elevation MI (NSTEMI), Troponin +ve ACS and ST Elevation MI (STEMI) in patients receiving thrombolysis. |
|||||
Solution for injection | |||||
Fondaparinux sodium (Non-proprietary) | Hospital only | ||||
Arixtra (Viatris UK Healthcare Ltd) | Hospital only | ||||
glyceryl trinitrate | Joint formulary choice | ||||
Sublingual tablet | |||||
Glyceryl trinitrate (Non-proprietary) | Joint formulary choice | ||||
Sublingual spray | |||||
Glyceryl trinitrate (Non-proprietary) | Joint formulary choice | ||||
Nitrolingual (Beaumont Pharma Ltd) | Joint formulary choice | ||||
Solution for infusion | |||||
Glyceryl trinitrate (Non-proprietary) | |||||
Nitronal (Beaumont Pharma Ltd) | |||||
Transdermal patch | |||||
Deponit (Forum Health Products Ltd) | Joint formulary choice | ||||
Minitran (Viatris UK Healthcare Ltd) | Joint formulary choice | ||||
Rectal ointment | |||||
Rectogesic (Kyowa Kirin International UK NewCo Ltd) | |||||
ivabradine | Specialist knowledge/initiation |
NICE TA267 |
|||
Oral tablet | |||||
Ivabradine (Non-proprietary) | |||||
Procoralan (Servier Laboratories Ltd) | |||||
metoprolol tartrate | Joint formulary choice | ||||
Solution for injection | |||||
Betaloc (Recordati Pharmaceuticals Ltd) | Hospital only | ||||
Oral tablet | |||||
Metoprolol tartrate (Non-proprietary) | |||||
nadolol | Not approved for prescribing | ||||
Oral tablet | |||||
Nadolol (Non-proprietary) | |||||
nicardipine hydrochloride | Not approved for prescribing | ||||
Solution for infusion | |||||
Nicardipine hydrochloride (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Oral capsule | |||||
Cardene (Laboratoire X.O) | |||||
nicorandil | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Nicorandil (Non-proprietary) | |||||
nifedipine | Joint formulary choice | ||||
Modified-release tablet | |||||
Adalat LA (Bayer Plc) | Joint formulary choice | ||||
Adanif XL (Advanz Pharma) | Joint formulary choice | ||||
Adipine MR (Chiesi Ltd) | Joint formulary choice | ||||
Adipine XL (Chiesi Ltd) | Joint formulary choice | ||||
Dexipress MR (Dexcel-Pharma Ltd) | |||||
Fortipine LA (Advanz Pharma) | Joint formulary choice | ||||
Neozipine XL (Kent Pharma (UK) Ltd) | |||||
Nifedipress MR (Dexcel-Pharma Ltd) | Joint formulary choice | ||||
Tensipine MR (Genus Pharmaceuticals Ltd) | Joint formulary choice | ||||
Valni Retard (Tillomed Laboratories Ltd) | Joint formulary choice | ||||
Modified-release capsule | |||||
Coracten SR (Teofarma S.r.l.) | Joint formulary choice | ||||
Coracten XL (Teofarma S.r.l.) | Joint formulary choice | ||||
Oral drops | |||||
Nifedipine (Non-proprietary) | Not approved for prescribing | ||||
Oral capsule | |||||
Nifedipine (Non-proprietary) | |||||
perindopril erbumine with amlodipine | |||||
pindolol | Not approved for prescribing | ||||
propranolol hydrochloride | Specialist knowledge/initiation | ||||
Modified-release capsule | |||||
Bedranol SR (Almus Pharmaceuticals Ltd, Sandoz Ltd) | Specialist knowledge/initiation | ||||
Beta-Prograne (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Half Beta-Prograne (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Oral solution | |||||
Propranolol hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Propranolol hydrochloride (Non-proprietary) | |||||
ranolazine | Specialist knowledge/initiation | ||||
Modified-release tablet | |||||
Ranolazine (Non-proprietary) | |||||
Ranexa (A. Menarini Farmaceutica Internazionale SRL) | Specialist knowledge/initiation | ||||
timolol maleate | Not approved for prescribing | ||||
Eye drops | |||||
Timolol maleate (Non-proprietary) | |||||
Eysano (Aspire Pharma Ltd) | |||||
Timoptol (Santen UK Ltd) | |||||
Tiopex (Thea Pharmaceuticals Ltd) | |||||
Eye gel | |||||
Timoptol-LA (Santen UK Ltd) | |||||
Oral tablet | |||||
Timolol maleate (Non-proprietary) | |||||
tirofiban | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
TIROFIBAN
The JPG agreed not to approve this medicine for use at the Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. |
|||||
Infusion | |||||
Tirofiban (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Aggrastat (Correvio UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Solution for infusion | |||||
Aggrastat (Correvio UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
verapamil hydrochloride | Specialist knowledge/initiation | ||||
Modified-release tablet | |||||
Half Securon (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
Securon SR (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
Verapamil for cluster headaches
Oral verapamil for cluster headaches should be prescribed under the explicit direction of a specialist only. |
|||||
Vera-Til SR (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Verapress MR (Dexcel-Pharma Ltd) | Specialist knowledge/initiation | ||||
Oral solution | |||||
Verapamil hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
Solution for injection | |||||
Securon (Viatris UK Healthcare Ltd) | Hospital only | ||||
Oral tablet | |||||
Verapamil hydrochloride (Non-proprietary) | |||||
Cardiovascular system / Acute coronary syndromes | |||||
alteplase | Hospital only |
NICE TA264 |
|||
Powder and solvent for solution for injection | |||||
Actilyse (Boehringer Ingelheim Ltd) | Hospital only | ||||
Powder and solvent for solution for infusion | |||||
Actilyse (Boehringer Ingelheim Ltd) | Hospital only | ||||
captopril | Not approved for prescribing | ||||
Oral solution | |||||
Captopril (Non-proprietary) | Not approved for prescribing | ||||
Oral tablet | |||||
Captopril (Non-proprietary) | |||||
clopidogrel | Joint formulary choice |
NICE TA210 |
|||
Oral tablet | |||||
Clopidogrel (Non-proprietary) | |||||
Plavix (Sanofi) | |||||
dalteparin sodium | Not approved for prescribing | ||||
Solution for injection | |||||
Fragmin (Pfizer Ltd) | Not approved for prescribing | ||||
enoxaparin sodium | Hospital only | ||||
Solution for injection | |||||
Arovi (ROVI Biotech Ltd) | |||||
Clexane (Sanofi) | Hospital only | ||||
Inhixa (Techdow Pharma England Ltd) | Hospital only | ||||
Ledraxen (Tetris Pharma Ltd) | |||||
glyceryl trinitrate | Hospital only | ||||
Sublingual tablet | |||||
Glyceryl trinitrate (Non-proprietary) | |||||
Sublingual spray | |||||
Glyceryl trinitrate (Non-proprietary) | |||||
Nitrolingual (Beaumont Pharma Ltd) | |||||
Solution for infusion | |||||
Glyceryl trinitrate (Non-proprietary) | Hospital only | ||||
Nitronal (Beaumont Pharma Ltd) | Hospital only | ||||
Transdermal patch | |||||
Deponit (Forum Health Products Ltd) | |||||
Minitran (Viatris UK Healthcare Ltd) | |||||
Rectal ointment | |||||
Rectogesic (Kyowa Kirin International UK NewCo Ltd) | |||||
heparin (unfractionated) | Hospital only | ||||
Solution for injection | |||||
Heparin (unfractionated) (Non-proprietary) | Hospital only | ||||
Infusion | |||||
Heparin (unfractionated) (Non-proprietary) | Hospital only | ||||
Form unstated | |||||
Heparin (unfractionated) (Non-proprietary) | Hospital only | ||||
isosorbide dinitrate | Not approved for prescribing | ||||
Modified-release tablet | |||||
Isoket Retard (Forum Health Products Ltd) | Not approved for prescribing | ||||
Solution for injection | |||||
Isosorbide dinitrate (Non-proprietary) | Hospital only | ||||
Isoket (Forum Health Products Ltd) | Hospital only | ||||
Solution for infusion | |||||
Isosorbide dinitrate (Non-proprietary) | Hospital only | ||||
Oral tablet | |||||
Isosorbide dinitrate (Non-proprietary) | |||||
isosorbide mononitrate | Joint formulary choice | ||||
Modified-release tablet | |||||
Isotard XL (Evolan Pharma AB) | Joint formulary choice | ||||
Modisal XL (Ennogen Pharma Ltd) | Joint formulary choice | ||||
Relosorb XL (Relonchem Ltd) | Joint formulary choice | ||||
Xismox XL (Genus Pharmaceuticals Ltd) | Joint formulary choice | ||||
Modified-release capsule | |||||
Elantan LA (Forum Health Products Ltd) | Joint formulary choice | ||||
Isodur XL (Galen Ltd) | Joint formulary choice | ||||
Monomax SR (Martindale Pharmaceuticals Ltd) | Joint formulary choice | ||||
Oral tablet | |||||
Isosorbide mononitrate (Non-proprietary) | |||||
lisinopril | Joint formulary choice | ||||
Oral solution | |||||
Lisinopril (Non-proprietary) | Joint formulary choice | ||||
Oral tablet | |||||
Lisinopril (Non-proprietary) | |||||
Zestril (Atnahs Pharma UK Ltd) | |||||
perindopril arginine | Not approved for prescribing | ||||
Oral tablet | |||||
Coversyl Arginine (Servier Laboratories Ltd) | |||||
perindopril erbumine | Joint formulary choice | ||||
Oral tablet | |||||
Perindopril erbumine (Non-proprietary) | |||||
prasugrel | Specialist knowledge/initiation |
NICE TA317 |
|||
Oral tablet | |||||
Prasugrel (Non-proprietary) | |||||
Efient (Vygoris Ltd) | |||||
ramipril | Joint formulary choice | ||||
Oral solution | |||||
Ramipril (Non-proprietary) | Joint formulary choice | ||||
Oral tablet | |||||
Ramipril (Non-proprietary) | |||||
Tritace (Sanofi) | |||||
Oral capsule | |||||
Ramipril (Non-proprietary) | |||||
streptokinase | Hospital only | ||||
Powder for solution for infusion | |||||
Streptokinase (Non-proprietary) | |||||
tenecteplase | Hospital only | ||||
Powder and solvent for solution for injection | |||||
Metalyse (Boehringer Ingelheim Ltd) | Hospital only | ||||
ticagrelor | Specialist knowledge/initiation |
NICE TA236 NICE TA420 |
|||
Orodispersible tablet | |||||
Brilique (AstraZeneca UK Ltd) | |||||
Oral tablet | |||||
Brilique (AstraZeneca UK Ltd) | |||||
trandolapril | Not approved for prescribing | ||||
Oral capsule | |||||
Trandolapril (Non-proprietary) | |||||
valsartan | Joint formulary choice | ||||
Oral solution | |||||
Diovan (Novartis Pharmaceuticals UK Ltd) | Joint formulary choice | ||||
Oral tablet | |||||
Valsartan (Non-proprietary) | |||||
Oral capsule | |||||
Valsartan (Non-proprietary) | |||||
Cardiovascular system / Cardiac arrest | |||||
adrenaline/epinephrine | Hospital only | ||||
Epipen®, Emerade® and Jext® are not used in exactly the same way
Please note different brands of adrenaline auto-injectors are not used in exactly the same way - specific training and advice is required for each of the devices. |
|||||
Solution for injection | |||||
Adrenaline/epinephrine (Non-proprietary) | Hospital only | ||||
Emerade (Bausch & Lomb UK Ltd) | |||||
Epipen®, Emerade® and Jext® are not used in exactly the same way
Please note different brands of adrenaline auto-injectors are not used in exactly the same way - specific training and advice is required for each of the devices. |
|||||
EpiPen (Viatris UK Healthcare Ltd) | |||||
Epipen®, Emerade® and Jext® are not used in exactly the same way
Please note different brands of adrenaline auto-injectors are not used in exactly the same way - specific training and advice is required for each of the devices. |
|||||
Jext (ALK-Abello Ltd) | |||||
Epipen®, Emerade® and Jext® are not used in exactly the same way
Please note different brands of adrenaline auto-injectors are not used in exactly the same way - specific training and advice is required for each of the devices. |